Acute pain. Acute pain
Conditions
Interventions
Intervention 1: Patients in the interventional group (first group) will be received an intravenous "Ketoroloc" 30 mg for 30 Sec. end of the operation in post anesthesia care uint immediately upon the
Treatment - Drugs
Patients in the interventional group (first group) will be received an intravenous "Ketoroloc" 30 mg for 30 Sec. end of the operation in post anesthesia care uint immediately upon the onset of pain
Patients in the the second group will receive " placebo" as same bolus volume of " Distilled Water " in a 30-Sec. intravenous infusion end of the operation in post anesthesia care uint immediately up
Sponsors
Vice-Chancellery of Research and Technology, Shiraz University Of Medical Sciences
Eligibility
Sex/Gender
All
Age
16 Years to 47 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria included 16-47 year old patients whom were scheduled to undergo mandibular fractured surgy; Subjects who had systemic disease and history of drug consumption; history of drug allergic reaction; hepatic and renal dysfunction and lack of signed informed consent will be excluded from the study sample
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity of postoperative pain. Timepoint: Immediately after surgery to 4 hours after surgery each 5 min. Method of measurement: VAS.;Use of narcotic (Pethedin) after surgery for postop. pain management. Timepoint: To 4 hours after surgery. Method of measurement: Nursing reports. | — |
Secondary
| Measure | Time frame |
|---|---|
| Post-operative complications of Ketoroloc. Timepoint: Immediately after surgery to 4 hours after surgery. Method of measurement: Nursing reports. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamid Reza Eftekharian
School of Dentistry, Shiraz University of Medical sciences
Outcome results
None listed